Keyword: Bicycle Therapeutics
Eisai installs new Alzheimer's clinical leadership team; Insys founder found guilty in landmark opioid suit; and Gilead's chief plots Kite CEO hire.
The hires provide Bicycle with clinical trial expertise at a time when it is contending with the resignation of its chief medical officer.
The British biotech wants the money to prepare for phase 2 and 3 clinical trials of its lead anticancer candidate, BT1718.
The appointment as SVP of preclinical development adds another set of footprints on the path from GlaxoSmithKline to Pfizer to Bicycle.
Biogen’s newly spun off hemophilia biotech Bioverativ has signed a new pact with U.K. biotech Bicycle Therapeutics.
Bicycle Therapeutics has returned to its big name backers for £40 million to fund the advance of cancer candidates into the clinic.
British research charity Cancer Research UK has teamed up with Bicycle Therapeutics, itself seeing the ink dry on a major deal with AstraZeneca this month, to trial BT1718 in advanced tumors.
AstraZeneca has penned a pact to develop bicyclic peptides with Bicycle Therapeutics.